How an integrated, digital tumor board tool reduced preparation time and case postponement rates in first, large prospective study


NAVIFY® Tumor Board demonstrated positive impacts in the preparation and conduction of a tumor board during a multiyear study with the Ellis Fischel Cancer Center at Missouri Healthcare.

Data was collected prospectively before the use of NAVIFY® Tumor Board (phase 1) through stable integration with the platform (phase 4). Data was collected across the breast, GI, hematopathology and ENT tumor boards looking at the following user groups across the institution: nurse navigators, pathology residents, radiologists and geneticists.

In this whitepaper you’ll learn:
 
  • Positive impacts that NAVIFY® Tumor Board had on case preparation, case discussion time and case postponement rates at the test site

  • Potential operational benefits seen at test site, including additional cases discussed and working days saved
 
 

 

Please fill out the form to download the whitepaper.